Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix to Annotate Promoters for Human Genome

Premium

Genomatix of Munich said it has initiated a project to annotate promoters for the entire human genome.

Using tools it developed, Genomatix said it can characterize large DNA sequences and predict functional promoters on a genomic scale. Promoters act as the molecular “switches” to regulate gene expression.

Genomatix said that based on the first published sequences from the human genome project (chromosomes 21 and 22) its approach is able to predict 50 percent of the previously characterized Polymerase II promoters from DNA sequences.

“From annotation of the two chromosomes (21, 22), we learned that about half of our independent predictions were confirmed by experimental evidence,” said Thomas Werner, CEO of Genomatix. “The fact that our methodology is very specific—low number of false positive predictions—will be of great importance to genome researchers.”

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.